These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 22178261)
1. Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors. Bajaj G; Kim MR; Mohammed SI; Yeo Y J Control Release; 2012 Mar; 158(3):386-92. PubMed ID: 22178261 [TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals. Sun B; Taha MS; Ramsey B; Torregrosa-Allen S; Elzey BD; Yeo Y J Control Release; 2016 Aug; 235():91-98. PubMed ID: 27238443 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer. Kim JE; Park YJ Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896 [TBL] [Abstract][Full Text] [Related]
4. Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis. Xu S; Fan H; Yin L; Zhang J; Dong A; Deng L; Tang H Eur J Pharm Biopharm; 2016 Jul; 104():251-9. PubMed ID: 27185379 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563 [TBL] [Abstract][Full Text] [Related]
6. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors. Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952 [TBL] [Abstract][Full Text] [Related]
7. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789 [TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
9. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303 [TBL] [Abstract][Full Text] [Related]
10. Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors. Zhu Y; Wang X; Chen J; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2016 Dec; 244(Pt B):229-239. PubMed ID: 27568289 [TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer. Cho EJ; Sun B; Doh KO; Wilson EM; Torregrosa-Allen S; Elzey BD; Yeo Y Biomaterials; 2015 Jan; 37():312-9. PubMed ID: 25453960 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts. Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803 [TBL] [Abstract][Full Text] [Related]
13. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel. Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677 [TBL] [Abstract][Full Text] [Related]
14. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy. Liang Y; Dong C; Zhang J; Deng L; Dong A Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206 [TBL] [Abstract][Full Text] [Related]
15. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy. Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167 [TBL] [Abstract][Full Text] [Related]
16. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876 [TBL] [Abstract][Full Text] [Related]
17. Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer. Xiao W; Suby N; Xiao K; Lin TY; Al Awwad N; Lam KS; Li Y J Control Release; 2017 Oct; 264():169-179. PubMed ID: 28847739 [TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer. De Clercq K; Xie F; De Wever O; Descamps B; Hoorens A; Vermeulen A; Ceelen W; Vervaet C Sci Rep; 2019 Oct; 9(1):14881. PubMed ID: 31619730 [TBL] [Abstract][Full Text] [Related]
19. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528 [TBL] [Abstract][Full Text] [Related]
20. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer. Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]